Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01886404 · ClinicalTrials.gov registry record
EFV Pharmacokinetics & Pharmacogenomics in Older HIV-infected Patients
A clinical trial, sponsored by University of Nebraska.
- Completed
- Registry status
- 30
- Enrollment target
NCT01886404 is a clinical trial that has completed, run by University of Nebraska. The registered enrollment target is 30 participants.
The verdict
NCT01886404 has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
The primary purpose of this study is to investigate the steady-state pharmacokinetics of efavirenz in older HIV-infected patients as compared to historical controls; to investigate the relationship of drug exposure to neuropsychiatric side effects and neuropsychological performance; and to explore the role of host polymorphisms in drug metabolism in the older patient.
Interventions
- DRUG Efavirenz
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2013-12-01 |
| Est. Completion | 2014-08-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01886404
The ClinicalTrials.gov registry entry for NCT01886404 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Efavirenz is the first listed.
NCT01886404 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01886404 about?
NCT01886404 is a clinical study titled "EFV Pharmacokinetics & Pharmacogenomics in Older HIV-infected Patients". The primary purpose of this study is to investigate the steady-state pharmacokinetics of efavirenz in older HIV-infected patients as compared to historical controls; to investigate the relationship of drug exposure to neuropsychiatric side effects and neuropsychological performance; and to explore t...
What is the current status of trial NCT01886404?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2013-12-01. Estimated completion is 2014-08-01.
What interventions are being tested in trial NCT01886404?
The interventions under investigation include: Efavirenz (DRUG).
Who is sponsoring clinical trial NCT01886404?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.